BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
The gross proceeds from the offering are expected to be approximately $2.5 million.
- The gross proceeds from the offering are expected to be approximately $2.5 million.
- BioSig intends to use the net proceeds of this offering for working capital and general corporate purposes.
- The securities described above are being offered by BioSig pursuant to a shelf registration statement on Form S-3 (File No.
- The securities offered in the registered direct offering are being offered only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement.